Productive Innovation - Portugal 2020

FINAO BIOTECH is a SME, created in July 2010 and headquartered in the BioBIP incubator at the Polytechnic Campus of Portalegre and is currently dedicated to licensing and marketing health products. With this project, the company seeks a more active position in the value chain of medical devices and health products, becoming a producer/manufacturer of medical devices (pharmaceutical preparations) and food supplements.

To achieve these goals, the company will build an industrial unit at the Industrial Park of Portalegre. This plant will produce solid, semi-solid and capsule medical devices and health products. The range of products to be produced involves gel, hydrogel to be impregnated in dressings, olive oil emulsions and açaí solutions.

Project title | Highly qualified employment in companies – Hiring Highly Qualified Human Resources

Project code | ALT20-05-3559-FSE-000065

Objectives of the Operation | Promoting employment and supporting labour mobility

Intervention region | Alto Alentejo

Beneficiary | FINAO Biotech, Lda.

Approval date | 24-07-2020

Start date | 04-05-2020

Conclusion date | 02-05-2023

Total eligible cost | 368.739,72 EUR

European union financial support | 184.369,86 EUR

Objectives, activities and expected results

FINAO Biotech is a company that sells health products, using an established international commercial network. Its expansion project aims to create a factory for its own production of innovative products for the markets where it operates. To carry out this project, new highly qualified resources will be needed to support the company’s productive and technological growth.

FINAO Biotech proposes the hiring of Highly Qualified Human Resourses (HQHR) to reinforce the company’s qualification and innovation strategy, in order to ensure the execution of the strategy and achieve the set objectives.

FINAO Biotech aims to be a reference in the sustainable development and production, distribution and commercialization of innovative health products, contributing to the creation of value. As strategic objectives, it focuses on consolidating and developing partnerships with pharmaceutical research and production companies, as well as with laboratories. It intends to impose itself on the global market and bet on the development of information technologies and process autonomy and also create an internet platform, e-Commerce for the sale of its products. With these actions, FINAO Biotech intends to increase its exports significantly and expand its workforce.